Does Histologic Activity Index (HAI) and ALT level Predict Response to Treatment For Hepatitis C with Conventional Interferon Alpha and Ribavarin?

2009 ◽  
Vol 104 ◽  
pp. S142
Author(s):  
Haq Nawaz ◽  
Saima Ambreen ◽  
Zahid Minhas ◽  
Muhammad Umer ◽  
Abdul Naeem ◽  
...  
2000 ◽  
Vol 124 (11) ◽  
pp. 1623-1627 ◽  
Author(s):  
Young Nyun Park ◽  
Peter Boros ◽  
David Y. Zhang ◽  
Patricia Sheiner ◽  
Leona Kim-Schluger ◽  
...  

Abstract Background.—Histopathologic features of early recurrent hepatitis C after orthotopic liver transplantation (OLTx) may be modified by immunosuppressive therapy or complicated by other conditions. Hepatitis C virus (HCV) RNA level usually increases after OLTx, but its correlation to histologic findings is not clear. Objective.—To evaluate the histologic findings of early recurrent hepatitis C in liver allografts and its correlation to serum HCV RNA level. Methods.—We studied 14 patients who underwent OLTx for chronic HCV infection. Thirty liver biopsy specimens and HCV RNA levels of 22 corresponding plasma samples obtained during the first 6 months following OLTx were analyzed. The control group (9 patients, 25 biopsy specimens) was chosen at random from patients with chronic liver disease other than HCV who were undergoing OLTx, and all tested negative for HCV RNA by polymerase chain reaction after OLTx. Results.—Statistically significant pathological features of early recurrent HCV infection were the number of acidophilic bodies, piecemeal necrosis, lymphocyte predominance in the portal tracts, and fibrous septum. These findings and histologic activity index scores increased with time after OLTx. The HCV RNA levels determined by branched DNA assay showed no significant correlation with histologic features. However, patients with higher histologic activity index scores tended to have higher RNA levels. Conclusions.—Liver biopsy specimens are helpful for the diagnosis or confirmation of early recurrent hepatitis C in liver allografts, but serial biopsy specimens are sometimes required for definite diagnosis. The HCV RNA levels are usually higher in patients who display signs of more severe liver damage.


2012 ◽  
Vol 2012 ◽  
pp. 1-6
Author(s):  
Amina Nadeem ◽  
Muhammad Aslam

Objective. To determine the association of thyroid dysfunction with the severity of the disease and response to treatment in patients of chronic hepatitis C. Design. Cohort study. Patients. One hundred and sixty seven noncirrhotic chronic hepatitis C patients were grouped into treatment group (n=107) and control group (n=60). Measurements. Baseline S. ALT and S. AST by IFCC and S. TSH, S. free T4, and S.T3 level were measured by chemiluminescence method. The severity of the disease was measured by Knodell histopathological index (HPI) on liver biopsy. Study group patients underwent 24-weeks IFN and ribavirin therapy and thyroid functions were determined at weeks 0, 12, and 24. Response to therapy was determined by PCR-HCV test. Results. 20 treated patients (18.69%) developed thyroid dysfunction with relative risk (RR) of 11.25 and attributable risk (AR) of 91%. Females were at higher risk. Hypothyroidism was common than hyperthyroidism. There was no significant association between thyroid dysfunction and severity of the disease (P=0.81) and response to therapy (P=0.79). Conclusion. Interferon-alpha and ribavirin therapy induces thyroid dysfunction in chronic hepatitis C patients. There is no association between severity of disease and response to therapy with interferon-induced thyroid dysfunction.


Author(s):  
Edison Roberto Parise ◽  
Ana Cláudia de Oliveira ◽  
Maria Lúcia Ferraz ◽  
Aparecido Bernardo Pereira ◽  
Kátia Ramos Leite

INTRODUCTION: The main extra-hepatic manifestation of hepatitis C is mixed cryoglobulinemia (MC). The aim of this study was to evaluate its prevalence among patients with chronic hepatitis C (CHC), to correlate its presence to host and virological variables and to the response to combined therapy with interferon-alpha and ribavirin. CASUISTIC AND METHODS: 202 CHC naive patients (136 with chronic hepatitis and 66 with cirrhosis) were consecutively evaluated for the presence of cryoglobulins. Cryoprecipitates were characterized by immunoelectrophoresis and classified according to the Brouet's criteria. RESULTS: The prevalence of MC was 27% (54/202), and 24% of them (13/54) showed major clinical manifestation of the disease. Even though type III MC was more frequent (78%), symptomatic MC was more common in type II MC. The presence of cirrhosis (RR = 2.073; IC95% = 1.029 - 4.179; p = 0.041), and age of the patients (RR = 1.035; IC95% = 1.008 - 1.062; p = 0.01) were independently associated with the presence of cryoglobulins. No relationship was found with viral load and genotype. 102 patients were treated with interferon alpha and ribavirin. Among these, 31 had MC. Sustained virological response (around 30%) was similar in patients with and without MC (p = 0.971). CONCLUSION: MC represents a prevalent complication in patients with CHC, specially older and cirrhotic patients. Only 24% of these patients show clinical manifestation of the disease, specially those with type II MC. The presence of MC did not affect the response to therapy.


Author(s):  
Martin Schäfer ◽  
Thomas Berg

<B>Ziel:</B> Übersicht zur Problematik der chronischen Hepatitis-C-Virus-(HCV)-Infektion bei Patienten mit intravenöser Drogenabhängigkeit. </P><P><B>Methodik:</B> Zusammenfassung und Interpretation aktueller Studien zur Epidemiologie und Therapie. </P><P><B>Ergebnisse:</B> HCV-infizierte drogenabhängige Patienten werden häufig von einer Therapie mit (Peg)-Interferon-alpha und Ribavirin ausgeschlossen. Studien der letzten Jahre zeigen jedoch, dass insbesondere bei Patienten in Methadonsubstitution Heilungsraten erzielt werden können, die vergleichbar sind mit langfristigen Ansprechraten in Kollektiven ohne Suchterkrankung. </P><P><B>Schlussfolgerungen:</B> Chronisch HCV-infizierte Patienten mit einer Drogenabhängigkeit müssen bei individueller Therapieentscheidung und interdisziplinärer Betreuung nicht von einer antiviralen Therapie ausgeschlossen werden. Weitere prospektive Studien werden jedoch benötigt.


Sign in / Sign up

Export Citation Format

Share Document